Due to multiple factors including content scraping and copyright infringement, Radio Free Hub City must now lock some of our more in-depth reporting behind a paywall, and many other articles will now require a free account to signup. Please click here to learn more.
The U.S. Food and Drug Administration (FDA) has issued a safety communication regarding glatiramer acetate, a medication used to treat relapsing forms of multiple sclerosis (MS). The FDA has added a Boxed Warning to the drug’s prescribing information, cautioning users about a rare but potentially fatal allergic reaction called anaphylaxis, which can occur at any point during treatment.
Continues after this brief message…
Did you know? Paid supporters get a reduced ad experience!
We know you value local news and entertainment that is free, open, and independent. Producing high-quality, paywall-free content isn't free. It takes time, effort, and resources to keep you informed and entertained. Unlike corporate media, we don’t have deep-pocketed investors or big advertisers funding our work—we rely on you, our readers and listeners, to keep Radio Free Hub City running. We're literally running on a shoe-string budget, but keep working hard to provide as much news and entertainment as we can.
If just 5% of local area residents became paid supporters at only $5 per month, we could meet our fundraising goals and continue expanding our news coverage depth while continuing to provide free access for everyone. So, if you'd like to help us in our continuing quest to improve our coverage, please consider becoming a paying supporter.
Will you be one of the 5%?
Thank you for supporting Radio Free Hub City!
Glatiramer acetate, marketed under the brand names Copaxone and Glatopa, is an injectable medication available in daily or thrice-weekly dosing schedules. Although immediate post-injection reactions—such as flushing, chest pain, or hives—are relatively common and self-resolving, anaphylaxis is rare, more severe, and requires urgent medical intervention. Symptoms of anaphylaxis, including wheezing, facial swelling, or difficulty breathing, typically appear within an hour of injection and may rapidly escalate.
Patients and caregivers are advised to seek emergency medical assistance if symptoms persist, worsen, or do not resolve promptly. The FDA has also warned that anaphylaxis can occur months or even years after initiating treatment. Those who experience this reaction should not resume the medication without identifying an alternative cause.
Article continues after these messages…
In a time where local news media coverage seems to be disappearing, your contribution is more important than ever. While our in-depth articles are for supporting members only, we won’t put our core news content behind a paywall, because we believe access to news should be democratized, instead of access for only those who can afford it.
But keeping the lights on and taking the fight to local accountability takes resources. Your monthly subscription directly funds our public records requests, website hosting, and time spent analyzing local government and events so you don’t have to.
We are the only newsroom in Washington County with facts-first focus, locally owned, independent, while keeping our core news content free. Will you help us keep it that way?
Healthcare professionals are urged to educate patients about the differences between immediate post-injection reactions and anaphylaxis, emphasizing the need for prompt action if severe symptoms develop. The FDA further advises against restarting the medication in patients with a history of anaphylaxis related to glatiramer acetate unless another clear cause is determined.
This new safety measure underscores the importance of vigilance in monitoring potential adverse reactions to glatiramer acetate. Patients with concerns are encouraged to consult their healthcare providers.
Article by multiple RFHC contributors.
Do you believe we got something wrong? Please read our publishing standards and corrections policy.
Video Spotlight
Did you know? Supporters get a reduced ad experience!
Sponsored Articles
Get daily and breaking news for Washington County, MD area from Radio Free Hub City. Sign up with your email today!
Paid supporters have a reduced ad experience!
Discover more from Radio Free Hub City
Subscribe to get the latest posts sent to your email.
